Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Management of Crohn's disease"'
Publikováno v:
Proceedings of the Nutrition Society. 80:409-423
The aetiology of inflammatory bowel disease (IBD) is multifactorial, with diet and gut microbiota playing an important role. Nonetheless, there are very few studies, particularly clinical research, which have explored the interaction between diet and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405892cd3a1e52b8df5cddcc271afa12
https://doi.org/10.1017/s0029665121002846
https://doi.org/10.1017/s0029665121002846
Publikováno v:
International Journal of Colorectal Disease
PurposeThe aim of this review was to examine current surgical treatments in patients with Crohn’s disease (CD) and to discuss currently popular research questions.MethodsA literature search of MEDLINE (PubMed) was conducted using the following sear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79534a71b36f46e03cd6793ae3e5a7fc
https://doi.org/10.1007/s00384-021-03857-2
https://doi.org/10.1007/s00384-021-03857-2
Publikováno v:
World Chinese Journal of Digestology. 28:660-668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87702d4d82a4f18799b7f8eac9696104
https://doi.org/10.11569/wcjd.v28.i15.660
https://doi.org/10.11569/wcjd.v28.i15.660
Autor:
Samir A. Shah, Uma Mahadevan, Ian M. Paquette, Jon D. Vogel, Sunanda V. Kane, Scott R. Steele, Joseph C. Carmichael, Amy L. Lightner, Daniel L. Feingold, Deborah S. Keller
Publikováno v:
Diseases of the Colon & Rectum. 63:1028-1052
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3970d31e4237fa14f8602684d0f08fb7
https://doi.org/10.1097/dcr.0000000000001716
https://doi.org/10.1097/dcr.0000000000001716
Publikováno v:
Clin Gastroenterol Hepatol
In the past decade, several new therapies with different mechanisms of action have been approved for the management of moderate to severe Crohn's disease. However, there is limited guidance on optimal positioning of agents as first- or second-line th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca6e1912547ede35145f320eb80f772
https://doi.org/10.1016/j.cgh.2019.10.035
https://doi.org/10.1016/j.cgh.2019.10.035
Autor:
Anjana Bali, Monika Rani
The initiation of Crohn’s disease, an inflammatory bowel disease, has been primarily associated with crypt inflammation and abscesses, which further progresses towards the development of mucosal lesion and ulcers followed by mucosal edema. Despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e0b8f783a8cdf6652a3baf9ab28da8
https://doi.org/10.5772/intechopen.97693
https://doi.org/10.5772/intechopen.97693
Autor:
Amr M. Ajlan, Turki Alhazmi, Ahmed Abduljabbar, Rani Ahmad, Ayman A. Eskander, Mohammad Wazzan, Khalid Khashoggi
Publikováno v:
Insights into Imaging
Insights into Imaging, Vol 12, Iss 1, Pp 1-8 (2021)
Insights into Imaging, Vol 12, Iss 1, Pp 1-8 (2021)
Objectives Crohn’s disease (CD) is a condition that can occur in any part of the gastrointestinal tract, although usually forms in the colon and terminal ileum. Magnetic resonance imaging (MRI) has become a beneficial modality in the evaluation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df4ef8914a9838cbd8c1f2198e50c7d
http://europepmc.org/articles/PMC8374012
http://europepmc.org/articles/PMC8374012
Publikováno v:
Gastroenterología y Hepatología (English Edition). 42:650-656
Vedolizumab is an anti-integrin monoclonal antibody indicated for the treatment of patients with moderately to severely active Crohn's disease and ulcerative colitis who have failed conventional or anti-TNF therapies. The objective of this article is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28d3abf17d0be89c36c6d9655b59b07
https://doi.org/10.1016/j.gastre.2019.08.003
https://doi.org/10.1016/j.gastre.2019.08.003
Publikováno v:
Revista Médica Clínica Las Condes, Vol 30, Iss 5, Pp 349-356 (2019)
Despite significant advances in medical therapy, particularly biological agents, a significant number of patients still need surgery as an important therapeutic tool in Crohn's disease (CD). The role of a surgeon in the multidisciplinary team in infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfef75f1b8148b1f9d3f81325f05c6d3
https://doi.org/10.1016/j.rmclc.2019.07.007
https://doi.org/10.1016/j.rmclc.2019.07.007
Publikováno v:
BMJ Case Reports
Active inflammatory bowel disease (IBD), combined immunosuppression and corticosteroid therapy have all been identified as risk factors for a poor outcome in COVID-19 infection. The management of patients with both COVID-19 infection and active IBD i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52901e12b10f822822351cd80570dc0a
https://pubmed.ncbi.nlm.nih.gov/33753379
https://pubmed.ncbi.nlm.nih.gov/33753379